| 000 | 01091 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515225518.0 | ||
| 264 | 0 | _c20100701 | |
| 008 | 201007s 0 0 eng d | ||
| 022 | _a1756-1833 | ||
| 024 | 7 |
_a10.1136/bmj.c2834 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChakravarthy, Usha | |
| 245 | 0 | 0 |
_aBevacizumab for the treatment of neovascular age related macular degeneration. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cJun 2010 |
||
| 300 |
_ac2834 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Editorial | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 | _aBevacizumab |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMacular Degeneration _xdrug therapy |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRanibizumab |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 340 _gp. c2834 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.c2834 _zAvailable from publisher's website |
| 999 |
_c19888530 _d19888530 |
||